Glenmark Philippines. Inc. is a subsidiary of Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company. Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast-growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 12,000 people in over 80 countries. It has fourteen manufacturing facilities in four countries and has five R&D centres.